Bruker Corporation - Common Stock (NQ:BRKR)

PreOmics GmbH and Biognosys AG Prevail in U.S. Patent Challenge

March 31, 2026

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...

3 Stocks Under $50 We Approach with Caution

March 30, 2026

CONMED, Bruker, Waters Corporation, Avantor, and Bio-Techne Stocks Trade Down, What You Need To Know

March 27, 2026

What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in...

What Happened? Shares of scientific instrument company Bruker (NASDAQ:BRKR). jumped 4% in the afternoon session after the company showcased novel analytical ...

Topics Government Stocks

Bruker (BRKR) Stock Is Up, What You Need To Know

March 24, 2026

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...

Topics Economy

3 Cash-Producing Stocks We Think Twice About

March 19, 2026

What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the hea...

Topics Intellectual Property

Bio-Techne, Bruker, DexCom, STERIS, and Teleflex Shares Plummet, What You Need To Know

March 06, 2026

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a...

Topics Economy

Research Tools & Consumables Stocks Q4 In Review: Bruker (NASDAQ:BRKR) Vs Peers

March 04, 2026

Over the past six months, Bruker has been a great trade, beating the S&P 500 by 16%. Its stock price has climbed to $41.37, representing a healthy 23.2% increase. This was partly thanks to its solid...

Topics Economy

Bruker (BRKR): Buy, Sell, or Hold Post Q4 Earnings?

February 26, 2026

Bruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics with the Launch of CellScape XR

Topics Stocks

February 25, 2026

Bruker Expands Collaboration with Noetik to Advance Tissue Foundational Models for Translational and Therapeutic Applications

February 24, 2026

Bruker Announces Major Advancements at AGBT to Enable Complete High-Fidelity Spatial Biology Across the Biological Spectrum

February 23, 2026

Bruker Advances Functional Proteomics 2.0 with timsOmniTM Mass Spectrometry Proteoform Analysis for Deeper Insights into Disease Biology

February 23, 2026

Bruker’s fourth quarter results were marked by ongoing weakness in U.S. academic and government funding, tariff-related cost pressures, and unfavorable currency movements. CEO Frank Laukien...

The Top 5 Analyst Questions From Bruker’s Q4 Earnings Call

February 19, 2026

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because...

Topics Earnings

1 of Wall Street’s Favorite Stock with Solid Fundamentals and 2 That Underwhelm

February 17, 2026

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my...

3 Profitable Stocks We Keep Off Our Radar

February 12, 2026

Shares of scientific instrument company Bruker (NASDAQ:BRKR). fell 10.4% in the morning session after the company reported fourth-quarter 2025 financial results that disappointed investors, highlighted...

Topics Economy

Why Bruker (BRKR) Stock Is Trading Lower Today

February 12, 2026

Bruker (BRKR) Q4 2025 Earnings Call Transcript

Topics Earnings

Bruker (BRKR) Q4 2025 Earnings Call Transcript ↗

February 12, 2026

Via The Motley Fool

Topics Earnings World Trade

Bruker’s (NASDAQ:BRKR) Q4 CY2025 Sales Beat Estimates

February 12, 2026

Scientific instrument company Bruker (NASDAQ:BRKR). reported Q4 CY2025 results exceeding the market’s revenue expectations, but sales were flat year on year at $977.2 million. The company’s full-year...

Topics Earnings

Bruker Reports Fourth Quarter and Full Year 2025 Financial Results

February 12, 2026

Bruker Introduces iNTApharma™, a Label‑Free Platform for Nanoparticle Characterization in mRNA Drug and Gene Therapy Development and QC

February 09, 2026

Chemspeed and SciY Announce Self‑Driving Laboratory Platform Integrating Automation, Analytics and AI Orchestration

February 09, 2026

Bruker Announces Quarterly Preferred Stock Dividend

February 05, 2026

Bruker Announces Date and Time of Fourth Quarter 2025 Earnings Release and Webcast

February 05, 2026

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have...

1 Healthcare Stock Worth Investigating and 2 That Underwhelm

January 15, 2026

Shares of scientific instrument company Bruker (NASDAQ:BRKR). fell 6.4% in the morning session after the company provided a weak organic revenue growth forecast for 2026 following a challenging 2025.

Topics Stocks

Why Bruker (BRKR) Shares Are Plunging Today

January 13, 2026

Bruker Announces $500 Million in Multi-Year Orders from Two Global Healthcare Companies for Supply of High-Performance Superconductors for MRI

Topics Artificial Intelligence Supply Chain

January 09, 2026

Bruker Consolidates Ownership of TOFWERK in Expansion of Mass Spectrometry Portfolio into New Applied Markets

January 08, 2026

Bruker Corporation to Present at the J.P. Morgan Healthcare Conference

January 07, 2026

Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps...

3 Unpopular Stocks We Think Twice About

January 06, 2026